99 related articles for article (PubMed ID: 16291879)
1. Lipid lowering agents to delay cognitive decline in Alzheimer's disease?
de Leeuw FE
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1611-3. PubMed ID: 16291879
[No Abstract] [Full Text] [Related]
2. Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease.
Masse I; Bordet R; Deplanque D; Al Khedr A; Richard F; Libersa C; Pasquier F
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1624-9. PubMed ID: 16291883
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort.
Sparks DL; Kryscio RJ; Connor DJ; Sabbagh MN; Sparks LM; Lin Y; Liebsack C
Neurodegener Dis; 2010; 7(1-3):183-6. PubMed ID: 20224282
[TBL] [Abstract][Full Text] [Related]
4. Does rivastigmine improve cognitive functions or disability in patients with Alzheimer's disease?
Cantisani TA; Celani MG; Righetti E
Neuroepidemiology; 2004; 23(4):209-10. PubMed ID: 15272224
[No Abstract] [Full Text] [Related]
5. Tacrine approved for cognitive deficits in Alzheimer's disease.
Nurse Pract; 1994 Jan; 19(1):6-8. PubMed ID: 8139805
[No Abstract] [Full Text] [Related]
6. Commentary on: L-methylfolate, methylcobolamine, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline.
Cummings JL
CNS Spectr; 2010 Jan; 15(1 Suppl 1):7. PubMed ID: 20397370
[No Abstract] [Full Text] [Related]
7. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
Strnad J; Bahro M
Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
[No Abstract] [Full Text] [Related]
8. Treatment strategies for the cognitive deficits of Alzheimer's disease.
Meador KJ
J S C Med Assoc; 1994 Nov; 90(11):543-7. PubMed ID: 7853858
[No Abstract] [Full Text] [Related]
9. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease.
Simpkins JW; Singh M; Bishop J
Neurobiol Aging; 1994; 15 Suppl 2():S195-7. PubMed ID: 7700453
[No Abstract] [Full Text] [Related]
10. Atherosclerosis in the evolution of Alzheimer's disease: can treatment reduce cognitive decline?
Luzzi S; Vella L; Bartolini M; Provinciali L; Silvestrini M
J Alzheimers Dis; 2010; 20(3):893-901. PubMed ID: 20182031
[TBL] [Abstract][Full Text] [Related]
11. [Current and future medical treatment of Alzheimer's disease].
Lemper JC
Rev Med Brux; 2005 Sep; 26(4):S294-9. PubMed ID: 16240877
[TBL] [Abstract][Full Text] [Related]
12. Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014.
Froestl W; Muhs A; Pfeifer A
J Alzheimers Dis; 2014; 41(4):961-1019. PubMed ID: 24898652
[TBL] [Abstract][Full Text] [Related]
13. Disease-modifying drug fails in Alzheimer's study.
Harv Ment Health Lett; 2010 Apr; 26(10):7. PubMed ID: 20503478
[No Abstract] [Full Text] [Related]
14. Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline.
Morris MC; Evans DA; Bienias JL; Scherr PA; Tangney CC; Hebert LE; Bennett DA; Wilson RS; Aggarwal N
J Neurol Neurosurg Psychiatry; 2004 Aug; 75(8):1093-9. PubMed ID: 15258207
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus.
Hanyu H; Sato T; Kiuchi A; Sakurai H; Iwamoto T
J Am Geriatr Soc; 2009 Jan; 57(1):177-9. PubMed ID: 19170800
[No Abstract] [Full Text] [Related]
16. [Treatment of Alzheimer's disease].
Bombois S; Lebert F; Vellas B; Pasquier F
Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
[TBL] [Abstract][Full Text] [Related]
17. [Cognitive functions blocked in Alzheimer's disease, an epigenetic mechanism revealed?].
Rei D
Med Sci (Paris); 2012 Dec; 28(12):1060-3. PubMed ID: 23290404
[No Abstract] [Full Text] [Related]
18. Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.
Pierrot N; Lhommel R; Quenon L; Hanseeuw B; Dricot L; Sindic C; Maloteaux JM; Octavea JN; Ivanoiu A
J Alzheimers Dis; 2016; 49(2):271-6. PubMed ID: 26444777
[TBL] [Abstract][Full Text] [Related]
19. New therapeutic approaches to Alzheimer's disease.
Schneider LS
J Clin Psychiatry; 1996; 57 Suppl 14():30-6. PubMed ID: 9024334
[TBL] [Abstract][Full Text] [Related]
20. Effects of antihypertensive therapy on cognitive decline in Alzheimer's disease.
Duron E; Rigaud AS; Dubail D; Mehrabian S; Latour F; Seux ML; Hanon O
Am J Hypertens; 2009 Sep; 22(9):1020-4. PubMed ID: 19590498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
